Sun Pharmaceutical Industries Ltd.

The Revenue for the quarter ended  June 2025 of Rs. 56019.60 millions grew by 24.54 % from Rs. 44980.70 millions.The company almost doubled its revenue to Rs. 7535.30 millions  from Rs. 2378.20 millions in the quarter ended June 2025.The company reported a good operating profit of 19948.40 millions compared to 8438.10 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202506	202406	% Var	202506	202406	% Var	202503	202403	% Var
Sales	56019.60	44980.70	24.54	56019.60	44980.70	24.54	230033.30	202751.70	13.46
Other Income	2932.10	827.40	254.38	2932.10	827.40	254.38	6239.70	4657.60	33.97
PBIDT	19948.40	8438.10	136.41	19948.40	8438.10	136.41	71620.50	60533.70	18.32
Interest	2232.90	2160.80	3.34	2232.90	2160.80	3.34	8932.10	7840.80	13.92
PBDT	14839.10	6277.30	136.39	14839.10	6277.30	136.39	62688.40	50502.70	24.13
Depreciation	2990.30	3698.10	-19.14	2990.30	3698.10	-19.14	12382.70	16006.20	-22.64
PBT	11848.80	2579.20	359.40	11848.80	2579.20	359.40	50305.70	34496.50	45.83
TAX	4313.50	201.00	2046.02	4313.50	201.00	2046.02	7479.50	5914.70	26.46
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	7535.30	2378.20	216.85	7535.30	2378.20	216.85	42826.20	28581.80	49.84
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	35.61	18.76	89.82	35.61	18.76	89.82	31.13	29.86	4.28